In recent years, challenges against branded pharmaceutical patents have become more sophisticated, resulting in more complex Hatch-Waxman and biosimilars patent litigation. This webinar will discuss tips and tricks for navigating through pharmaceutical patent litigation and Patent Trial and Appeal Board (“PTAB”) proceedings and will address potential strategies for branded pharmaceutical companies to prepare for newly trending attacks and avoid possible pitfalls. Topics discussed in this webinar include:
- “Design-around” strategies in attempts to avoid patent infringement
- Use of the PTAB by challengers as a second front in patent litigation
- “Shape-shifting” patent attacks that pit infringement and validity positions or different validity positions against one another
- Trends in using, or avoiding, the “patent dance” for biosimilars patent litigation under the BPCIA
CLE credit will be applied for in CA, GA, IL, NY, TX and, if needed, NC and VA. Attendees will receive a Uniform Certificate of Attendance via email approximately 30 days after the program to seek CLE credit in other jurisdictions. New York lawyers: This program is considered transitional and non-transitional in content. The interactive webinar format is synchronous and approved for all lawyers. King & Spalding LLP | 1180 Peachtree Street NE, Atlanta, GA 30309 | CA Provider #10947.
General information on our practice is available in our electronic publications Serving the Life Sciences Industry and Serving the Healthcare Industry. If you would like to be included on our regular pharmaceutical manufacturers, medical device manufacturers or healthcare provider mailing lists to receive notices of other events and written updates, you can be added by submitting your full contact information to firstname.lastname@example.org and specifying the list you wish to join.
If you have questions concerning this roundtable webinar, email email@example.com.